New strategies for anticoagulation therapy after LAA closure

19 March 2018 (17:42 - 18:00)

Organised by:

Video

Slides

Sign in for access options

About the speaker

Professor Michael Glikson

Shaare Zedek Medical Center, Jerusalem (Israel)

5 More presentations in this session

Presentation thumbnail

This session is supported by Abbott and Boston Scientific in the form of an educational grant. The scientific programme has not been influenced in any way by these sponsors.

Presentation thumbnail

Stroke prevention or bleeding: how to weigh the results of clinical trials

Professor L. Boersma (Nieuwegein, NL)

Presentation thumbnail

The role of the LAA for AF and stroke: fact or fiction

Professor T. Lewalter (Munich, DE)

Presentation thumbnail

LAA closure concomitant to AF ablation - The surgical perspective

Associate Professor S. Salzberg (Zurich, CH)

Presentation thumbnail

LAA closure concomitant to AF ablation - The EP perspective

Professor C. Tondo (Milano, IT)

Access the full session

Session thumbnail

Novel insights of LAA treatment for atrial fibrillation and stroke prevention

The Event

EHRA 2018

19 March 2018 17:42 CET

You may be interested in

Congress Presentation

Left atrial appendage closure: who should get it and how to manage patients medically before, during and after?

27 August 2023

Congress Presentation

Single versus dual antiplatelet therapy following transcatheter left atrial appendage closure

4 April 2022

Congress Session

EHRA honorary lectures

31 March 2025

Congress Presentation

Left atrial appendage closure after severe bleeding in anticoagulated patients with atrial fibrillation and cancer: real world data from PERSEO registry

20 June 2025

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources